Detalles de la búsqueda
1.
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res
; 24(1): 229, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749551
2.
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Respir Res
; 25(1): 152, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561735
3.
Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy.
BMJ Open Respir Res
; 11(1)2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448044
4.
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study.
BMJ Open
; 14(2): e072361, 2024 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38326272
5.
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany.
Int J Chron Obstruct Pulmon Dis
; 19: 945-956, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38646606
6.
Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
Respir Med
; 226: 107630, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593886
7.
Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims study.
Respir Med
; 226: 107629, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593885
8.
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study.
BMJ Open Respir Res
; 11(1)2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772900
9.
Burden of Disease in Patients with Mild or Mild-to-Moderate Chronic Obstructive Pulmonary Disease (Global Initiative for Chronic Obstructive Lung Disease Group A or B): A Systematic Literature Review.
Int J Chron Obstruct Pulmon Dis
; 18: 719-731, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37151760
10.
Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting ß2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England.
Int J Chron Obstruct Pulmon Dis
; 18: 231-245, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36908830
11.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting ß2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England.
Int J Chron Obstruct Pulmon Dis
; 18: 643-659, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37155496
12.
Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study.
Int J Chron Obstruct Pulmon Dis
; 18: 2933-2953, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089540
13.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England.
Int J Chron Obstruct Pulmon Dis
; 18: 2039-2054, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731774
14.
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England.
Int J Chron Obstruct Pulmon Dis
; 18: 1431-1444, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37465818
15.
A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
Respir Med
; 191: 106670, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34883444
16.
Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting ß2-Agonist Dual Therapy in a Primary Care Setting in England.
Int J Chron Obstruct Pulmon Dis
; 17: 1781-1795, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983168
17.
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting ß2-agonist dual therapy in a primary care setting in England.
BMJ Open Respir Res
; 9(1)2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36171051
18.
Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
Adv Ther
; 39(9): 3957-3978, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35849317
19.
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
Int J Chron Obstruct Pulmon Dis
; 17: 2417-2429, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36185170
20.
Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis.
Adv Ther
; 39(11): 4961-5010, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35857184